EUVIMEDEUVIMED entdecken
Crossref

L26/P-462 Reducing Barriers to Fertility Care Through Remote Reproductive Health Testing

Z. Ali, E. Wainwright, N. Getreu, H. C. O’ Neill

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Z. Ali und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can remote reproductive health testing address patient-reported barriers to accessing fertility care and influence subsequent engagement with healthcare services? Summary answer Remote reproductive health testing was associated with improved patient understanding and increased engagement with fertility-related care among individuals reporting barriers within traditional care pathways. What is known already Access to timely fertility care in the UK is frequently delayed by long NHS waiting times, limited specialist availability, perceived dismissal of patient concerns and fragmented care pathways. These barriers may delay diagnosis and treatment and contribute to emotional distress. Telemedicine and remote testing have been proposed as potential tools to support earlier assessment and patient engagement, though real-world evidence remains limited. This study explored patient motivations for using remote testing, barriers encountered in traditional care, and the impact of remote access on care-seeking. Study design, size, duration A cross-sectional survey was conducted with 331 individuals actively trying to conceive (TTC) who had recently completed remote reproductive health testing. Participants/materials, setting, methods Participants self-reported demographic information, prior diagnostic status, healthcare utilisation, perceived barriers to accessing fertility care, and actions taken following testing. Descriptive analyses were performed to characterise barriers, diagnostic outcomes, and post-testing care-seeking behaviours. Descriptive analyses were performed. Main results and the role of chance Prior to testing, 67.7% (n = 224) reported no fertility-impacting condition, while 19.9% (n = 66) did, and 5.4% (n = 18) were awaiting NHS specialist assessment. Commonly reported barriers included long NHS wait-time (41.4%), feeling unheard by healthcare professionals (36.9%), difficulty accessing fertility services (36.6%), uncertainty about where to seek care (36.6%), and guidance on next steps (29.0%). Over half of participants (51.7%) relied exclusively on NHS services prior to testing. Following testing, 22.4% (n = 74) reported receiving a diagnosis through the remote pathway, exceeding diagnoses obtained through NHS routes (19.0%, n = 63), most commonly polycystic ovary syndrome (6.0%) and thyroid dysfunction (4.2%). Testing prompted concrete action, 41.1% consulted a healthcare professional, 41.1% arranged further investigations, 25.7% implemented lifestyle changes, and 13.6% initiated fertility treatment and 12.9% reported being able to access care previously perceived as inaccessible.Beyond clinical action, participants reported meaningful personal impact. Improved understanding of reproductive health was reported by 37.2%, greater confidence in decision-making by 22.8%, and receipt of previously unavailable information by 20.5%. Overall, 52.0% described a moderate to significant impact on decision-making, with 9.1% reporting a life-changing impact. Post-testing outcomes included spontaneous pregnancy (45.3%), pregnancy following treatment (5.1%), ongoing difficulty conceiving (26.3%), or active fertility treatment (9.1%) at the time of survey completion. Limitations, reasons for caution Findings are based on self-reported survey data and are therefore subject to recall and reporting bias. Participants were self-selected users of remote reproductive health testing, which may limit generalisability to broader populations accessing fertility care through traditional pathways. Wider implications of the findings Remote reproductive health testing can help overcome systemic and informational barriers to fertility care by enabling earlier diagnostic insight and empowering patients to seek targeted support. These findings suggest that remote, personalised testing may complement traditional care pathways, improve patient understanding, and facilitate timely access to appropriate fertility services. Trial registration number No

Zitieren

APA

Ali, Z., Wainwright, E., Getreu, N., & Neill, H. C. O. (2026). L26/P-462 Reducing Barriers to Fertility Care Through Remote Reproductive Health Testing. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.796

Vancouver

Ali Z, Wainwright E, Getreu N, Neill HCO. L26/P-462 Reducing Barriers to Fertility Care Through Remote Reproductive Health Testing. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.796

BibTeX
@article{Ali2026,
  author = {Ali, Z. and Wainwright, E. and Getreu, N. and Neill, H. C. O’},
  title = {L26/P-462 Reducing Barriers to Fertility Care Through Remote Reproductive Health Testing},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.796}
}
Kostenlos starten →